Stock Groups

Is Celldex Therapeutics Headed for a Breakout? By StockNews

by Mike Robinson

[ad_1]

© Reuters. Celldex Therapeutics Is Getting Ready for a Breakout

In the chart, a resistance line has been drawn and there is a level support. Celldex Therapeutics Inc. The resistance will likely be broken at some point. If this occurs, the stock will likely breakout. You can learn more about how to profit in this trade. Celldex Therapeutics Inc. It is concerned with the commercialization and development of immunotherapy technologies as well as other cancer-targeting biologics. Clinical trials are also being conducted for breast, metastatic, lung, solid, and ovarian carcinoma products.

In a study that was in its early stages for the experimental antibody therapy CDX-0159, the company posted strong results this summer. Last month, the company also announced it had begun dosing for the first phase of its drug-evaluation study.

It appears that the company has a strong balance sheet with $164million in cash and $1 million long-term debt. Sales are growing by 90.7% in the last year, and they are projected to rise 212.8% in the current quarter. This will result in a Growth Grade B in our POWR Ratings.

Continue reading on StockNews

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]